600+ sources. One page. See who else covered it.
(MedPage Today) -- The CDC on Tuesday warned doctors about the risk for severe arboviral neuroinvasive disease in patients on B cell-depleting or modulating agents, calling out anti-CD20 monoclonal antibodies in particular. Published case reports...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The Trump administration on Tuesday finalized a plan to cut off federal Medicaid funding for hormone therapy, puberty blockers and surgeries for transgender youths.
Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.
Steve Ostroff, Former Acting Commissioner of the FDA and Former Deputy Director of the National Center for Infectious Diseases at the CDC, joined the program to discuss the public awareness timeline…
Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than surgery alone in…
Researchers at the University of California San Diego and their colleagues have identified a key cellular pathway that drives brain degeneration in both a rare childhood disorder and the far more…
Manitoba's addictions minister says it's a special but bittersweet day as the province opens its first supervised consumption site in Winnipeg.